Search Results - "Earhart, R"

Refine Results
  1. 1
  2. 2

    A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer by Valero, V, Jones, S E, Von Hoff, D D, Booser, D J, Mennel, R G, Ravdin, P M, Holmes, F A, Rahman, Z, Schottstaedt, M W, Erban, J K, Esparza-Guerra, L, Earhart, R H, Hortobagyi, G N, Burris, 3rd, H A

    Published in Journal of clinical oncology (01-10-1998)
    “…To evaluate the efficacy and safety of docetaxel in patients with paclitaxel-resistant metastatic breast cancer (MBC). Docetaxel (100 mg/m2) was administered…”
    Get more information
    Journal Article
  3. 3

    Docetaxel (Taxotere): preclinical and general clinical information by Earhart, R H

    Published in Seminars in oncology (01-10-1999)
    “…Docetaxel (Taxotere; Rhône-Poulenc Rorer, Collegeville, PA) is the second member of the taxane class of cytotoxic agents to reach clinical use. The development…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancer by Belani, C.P., Einzig, A., Bonomi, P., Dobbs, T., Capozzoli, M. J., Earhart, R., Cohen, L. J., Luketich, J. D.

    Published in Annals of oncology (01-06-2000)
    “…Purpose; To evaluate the safety and efficacy of docetaxel and carboplatin as first-line therapy for patients with advanced non-small-cell lung cancer (NSCLC)…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Phase I study of adozelesin administered by 24-hour continuous intravenous infusion by Fleming, G F, Ratain, M J, O'Brien, S M, Schilsky, R L, Hoffman, P C, Richards, J M, Vogelzang, N J, Kasunic, D A, Earhart, R H

    “…Adozelesin, a synthetic analogue of the antitumor antibiotic CC-1065, is the first of a class of potent sequence-specific alkylating agents to be brought to…”
    Get more information
    Journal Article
  10. 10

    Phase 1 trial of oral bropirimine in superficial bladder cancer by Sarosdy, M F, Lamm, D L, Williams, R D, Moon, T D, Flanigan, R C, Crawford, E D, Wilks, N E, Earhart, R H, Merritt, J A

    Published in The Journal of urology (01-01-1992)
    “…A total of 34 patients with measurable superficial transitional cell cancer of the bladder entered into a phase 1, nonrandomized, noncomparative trial to…”
    Get more information
    Journal Article
  11. 11

    Evidence for paracrine regulation of experimental metastasis in 13762NF rat mammary adenocarcinoma cell clones by Welch, D R, Aeed, P A, Earhart, R H, McClure, S A

    Published in Anticancer research (01-09-1994)
    “…The ability of tumor cell lines to form experimental pulmonary metastases is determined in part by characteristics which are stable over many cell generations;…”
    Get more information
    Journal Article
  12. 12

    Phase I study of adozelesin (U-73,975) in patients with solid tumors by Shamdas, G J, Alberts, D S, Modiano, M, Wiggins, C, Power, J, Kasunic, D A, Elfring, G L, Earhart, R H

    Published in Anti-cancer drugs (01-02-1994)
    “…During a phase I clinical and pharmacologic trial, 26 patients with refractory solid tumors were treated with increasing doses of adozelesin by brief…”
    Get more information
    Journal Article
  13. 13

    Phase I clinical trial and pharmacokinetics of carboplatin (NSC 241240) by single monthly 30-minute infusion by Koeller, J M, Trump, D L, Tutsch, K D, Earhart, R H, Davis, T E, Tormey, D C

    Published in Cancer (15-01-1986)
    “…Carboplatin (diammine [1,1-cyclobutanedicarboxylate(2-)-O,o']platinum) is a second generation platinum coordination complex. It has a spectrum of activity that…”
    Get more information
    Journal Article
  14. 14

    209 Initiating a Statewide Evaluation System for Watermelons by Brandenberger, L, Baker, M, Bender, D, Dainello, F, Earhart, R, Parsons, J, Roberts, R, Roe, N, Stein, L, Valdez, M, White, K, Wiedenfeld, R

    Published in HortScience (01-06-1999)
    “…During the past several years, watermelon trials have been performed in the state, but not as a coordinated effort. Extensive planning in 1997 led to the…”
    Get full text
    Journal Article
  15. 15

    Randomized phase II study of picoplatin in combination with 5-fluorouracil and leucovorin (FOLPI) as a neuropathy-sparing alternative to modified FOLFOX-6 as first-line therapy for colorectal cancer (CRC) by Earhart, R., Cheporov, S., Gladkov, O., Biakhov, M., Breitz, H., De Jager, R.

    Published in Journal of clinical oncology (20-05-2009)
    “…Abstract only 4026 Background: Picoplatin (Pico) was designed to overcome platinum resistance and has the potential for improved safety compared to other…”
    Get full text
    Journal Article
  16. 16

    Results of a phase II study of picoplatin with docetaxel and prednisone in first-line treatment of castration-resistant prostate cancer (CRPC) by De Jager, R. L., Roman, L., Lopatkin, N., Karlov, P., Breitz, H., Earhart, R.

    Published in Journal of clinical oncology (20-05-2009)
    “…Abstract only 5140 Background: Picoplatin (Pico) was designed to overcome platinum resistance and has the potential for improved safety compared to other…”
    Get full text
    Journal Article
  17. 17

    Interactions of poultry litter, polyethylene mulch, and floating row covers on triploid watermelon by Baker, J.T. (Texas AandM University Agricultural Research and Extension Center, Overton, TX.), Earhart, D.R, Baker, M.L, Dainello, F.J, Haby, V.A

    Published in HortScience (01-08-1998)
    “…Triploid watermelon (Citrullus lanatus Thunb.) was grown on the same plots in 1990 and 1991 and fertilized with either poultry litter or commercial fertilizer…”
    Get full text
    Journal Article
  18. 18

    Phase I study of weekly intravenous administration of menogaril to adults with solid tumors by Stewart, D J, Maroun, J A, Verma, S, Perrault, D, Earhart, R H

    Published in American journal of clinical oncology (01-12-1989)
    “…Thirty-nine adults with solid tumors were treated on a Phase I study of menogaril administered i.v. once each week. Granulocytopenia was dose-limiting at a…”
    Get more information
    Journal Article
  19. 19

    Phase I clinical trial of a combination of dipyridamole and acivicin based upon inhibition of nucleoside salvage by WILLSON, J. K. V, FISCHER, P. H, RANHOSKY, A, TRUMP, D. L, TUTSCH, K, ALBERTI, D, SIMON, K, HAMILTON, R. D, BRUGGINK, J, KOELLER, J. M, TORMEY, D. C, EARHART, R. H

    Published in Cancer research (Chicago, Ill.) (01-10-1988)
    “…A Phase I clinical trial of simultaneous 72-h infusions of dipyridamole and acivicin was carried out in patients with advanced malignancies. The objective of…”
    Get full text
    Journal Article
  20. 20

    Phase I study with the DNA sequence-specific agent adozelesin by Burris, H A, Dieras, V C, Tunca, M, Earhart, R H, Eckardt, J R, Rodriguez, G I, Shaffer, D S, Fields, S M, Campbell, E, Schaaf, L, Kasunic, D, Von Hoff, D D

    Published in Anti-cancer drugs (01-07-1997)
    “…Adozelesin, a synthetic analog of the antitumor antibiotic CC-1065, is a novel cytotoxic agent which inhibits DNA synthesis by binding to the minor groove of…”
    Get more information
    Journal Article